“celgene” Archives

in
Entry Author Date Location
Dragonfly, eGenesis, Spero & More: Xconomy’s Startup Award Finalists 08/14/17 Boston
Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More 08/11/17 National
Celgene Narrows Its Relationship With Sutro, No Acquisition Coming 08/10/17 New York
Startup Builders, IPO Closers & More: Meet Xconomy’s CEO Award Finalists 08/10/17 Boston
Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More 08/04/17 National
IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout 08/03/17 Boston
With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug 08/01/17 Boston
Invenra Signs On With Merck in Antibody Discovery Partnership 07/28/17 Wisconsin
Bio Roundup: GOP Drama, Immunotherapy Setbacks, Pharma Revamps 07/28/17 National
Eli Lilly Pays Nektar $150M Up Front For Autoimmune Drug Rights 07/24/17 Indiana
Evelo Bio Raises $50M Round to Bring Microbiome Drugs Into Trials 07/11/17 Boston
Bio Roundup: BCRA Fireworks, Shkreli Muzzled, Endo Pulls Drug & More 07/07/17 National
Celgene Builds Up Cancer Drug Pipeline With BeiGene Deal 07/06/17 New York
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal 06/12/17 Boston
Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More 05/26/17 National
Celgene’s Data Could Lead To New Option For Multiple Sclerosis Patients 05/22/17 New York
Ex-Sarepta CEO Garabedian Returns to Run Bio Accelerator Xontogeny 05/18/17 Boston
Zymeworks Bags $58M in IPO to Bankroll Cancer Drug Trials 04/28/17 Seattle
OncoMed Slashes Workforce After Two Clinical Trial Failures in Cancer 04/24/17 San Francisco
OncoMed Shares Sink as One Drug Fails, Bayer Kicks Back Two Others 04/10/17 San Francisco
Third Rock’s Tango Aims For Drugs That Turn Cancer Against Itself 03/30/17 Boston
Invenra Adds Partners, Still Open to Developing Own Drugs in Future 03/14/17 Wisconsin
Drugmakers, Amazon Back Grail’s Big Cancer Trials With $900M 03/01/17 San Francisco
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills 02/27/17 Boston
Harvard’s Verdine Aims to Retire, Become Full-Time FogPharma CEO 02/23/17 Boston
Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More 02/17/17 National
With $20M, UCSD Spinout Jecure To Press New Attack On NASH 02/15/17 San Diego
Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins 02/03/17 National
Drug-Hunting Startup From Scripps Attracts Celgene Alum, $50M Backing 02/02/17 San Diego
Page 1 of 14 next page »